Nvidia Has Already Dropped $40 Billion on AI Deals in 2026: and the Biggest Bet Is on OpenAI
Nvidia isn't just the pick-and-shovel seller of the AI gold rush anymore. It's become the venture capitalist writing the checks....
Nvidia isn't just the pick-and-shovel seller of the AI gold rush anymore. It's become the venture capitalist writing the checks....
Title: Nintendo Drops a Bombshell: Switch 2 Gets $50 Price Hike Worldwide Feature Image: https://images.unsplash.com/photo-1593305841991-05c297ba4575?...
Elon Musk's SpaceX has filed plans to invest $55 billion—potentially ballooning to $119 billion—in a sprawling semiconductor manufacturing complex in ...
🔥 Wall Street Just Fired the Opening Shot in the Crypto Fee Wars...
Starting a tech business in 2026 costs less than ever. Cloud infra is cheap. AI handles the work a whole team used to do. You can launch a SaaS produc...
Databricks just repriced 40% higher to $188 billion in seven months — a ~$3B round led by Coatue, still stubbornly private, and quietly running the AI economy's plumbing.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Developer documentation is the silent killer of product adoption. A 2025 study by the Developer Marketing Alliance found that 67% of developers will a...
Vera Therapeutics just won FDA accelerated approval for TRUTAKNA, the first dual BAFF/APRIL inhibitor for IgA nephropathy — priced at $425,000 a year. Here's why the two-target bet matters.
Feature Image: https://images.unsplash.com/photo-1648792940059-3b782a7b8b20?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3w3ODQzODd8MHwxfHNlYXJj...
BREAKING NEWS — In a move that signals the pharmaceutical industry's full-scale embrace of artificial intelligence, Swiss healthcare giant Roche has ...